Synergetics USA: Shift in Corporate Strategy Yields Strong First Quarter Results

Synergetics USA reported first quarter revenues of $12.2 million, an increase of 17% over the year ago period. More compelling was the increase in net income: $661,000 in the most recent quarter compared to $397,000 in Q1 2008, a 66% improvement. In the past year, the Synergetics team, led by Chairman Robert...

Patient Enrollment for Monovisc U.S. Clinical Trial Complete

Anika Therapeutics, a developer of products for tissue protection, healing and repair, has completed patient enrollment for its Monovisc U.S. clinical trial. The randomized, double-blind study is designed to demonstrate that the single-injection viscosupplement therapy safely provides knee pain relief in...

[Video Profile] CoreSpine Technologies

CoreSpine Technologies is a Minneapolis, MN-based orthopedics company developing a device to prepare the spinal disc space prior to surgery. The company’s platform removes material from the lumbar disc space to prepare the area for artificial nucleus replacement or other minimally invasive fusion devices....

AngioDynamics Seeks CEO, Issues Downside Guidance

Changes are afoot at Queensbury NY-based AngionDynamics. The company said yesterday that it would begin the search for a new CEO to replace company co-founder Eamonn Hobbs. Hobbs (pictured) will continue on as Vice Chairman of the Board of Directors where he will focus on the company’s newly acquired...

[Video Profile] EyeMarker Systems

EyeMarker Systems is developing an ocular imaging device that can determine if a person has been exposed to certain toxic agents (botulinum, nerve agents, cyanide) in less than two minutes. The company has been bankrolled by the Defense Advanced Research Projects Agency (DARPA), which you may know for the...

[Device Profile] Sunshine Heart’s C-Pulse

Good news for the 1.4 million U.S. patients now living with moderate heart failure: Sunshine Heart is developing a new mechanical heart assist device, C-Pulse. The implantable aortic cuff is designed to bridge the clinical gap between heart failure pacemakers and existing end stage therapies (details here)....

Biolase Cuts Jobs Citing a Weak Capital Equipment Marketplace

Dental laser maker Biolase Technology has slashed 20 percent of its domestic workforce. The company will save $2 million a quarter as a result. Additional cost savings initiatives are now being explored in the company’s international subsidiaries. “In the short-term, this creates a leaner...

OneMedForum 2009: Panels and Speakers

The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Click here to learn more. Our featured panelists and speakers will be recognized experts that can offer insights and a unique perspective on their respective area of expertise....